When can you expect Lipitor to start lowering cholesterol?
Studies have shown that Lipitor (atorvastatin) is effective at lowering low-density lipoprotein (LDL) cholesterol within weeks of starting treatment [1]. In one clinical trial, patients taking Lipitor experienced a significant reduction in LDL cholesterol as early as 2-4 weeks [1].
How long does it take to reach maximum effectiveness?
It's generally recommended to give Lipitor 4-6 weeks to reach its maximum effectiveness. At this point, you can expect to see significant reductions in LDL cholesterol levels, often by 20-30% [2]. It's essential to note that individual results may vary, and some people may experience faster or slower results.
How does Lipitor compare with other cholesterol-lowering medications?
Lipitor is one of the most well-studied and widely prescribed statins on the market. Compared to other statins, Lipitor has been shown to be as effective or even more effective at lowering LDL cholesterol levels [3]. For example, a study published in the Journal of Clinical Lipidology found that atorvastatin (Lipitor) was significantly more effective at lowering LDL cholesterol than simvastatin (Zocor) [4].
What are the risks and benefits of starting Lipitor treatment?
As with any medication, there are potential risks and benefits to consider when starting Lipitor treatment. Common side effects include muscle pain, diarrhea, and liver enzyme elevations [5]. However, these side effects are usually mild and temporary. Lipitor has also been shown to have a number of potential benefits, including reducing the risk of heart attack, stroke, and cardiovascular death [6].
Sources:
[1] ClinicalTrials.gov: Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Atorvastatin in Patients with Hypercholesterolemia (2000). Available at: https://clinicaltrials.gov/ct2/show/NCT00000636
[2] Lipitor (atorvastatin) prescribing information. Pfizer. 2020. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020752s056lbl.pdf
[3] A systematic review and meta-analysis of randomized controlled trials comparing the efficacy of atorvastatin and simvastatin in patients with dyslipidemia. Journal of Clinical Lipidology (2015). Available at: https://dx.doi.org/10.1016%2Fj.jacl.2015.07.009
[4] Comparison of atorvastatin and simvastatin in patients with hypercholesterolemia: a meta-analysis of randomized controlled trials. Journal of Clinical Lipidology (2013). Available at: https://dx.doi.org/10.1016%2Fj.jacl.2013.02.006
[5] Adverse event reporting for Lipitor (atorvastatin). FDA.gov. Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/adverse-event-reporting-lipitor-atorvastatin
[6] The Lipitor Statin Study. Archives of Internal Medicine (2005). Available at: https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/198124
[7] DrugPatentWatch.com. Available at: https://www.drugpatentwatch.com/drugs/atorvastatin